Leerink Partners analyst Michael Cherny reiterated a Hold rating on Certara (CERT – Research Report) on April 11. The company’s shares closed ...

Fintel reports that on April 8, 2025, Leerink Partners initiated coverage of Spyre Therapeutics (NasdaqGS:SYRE) with a ...

In a report released on April 4, Michael Cherny from Leerink Partners maintained a Hold rating on Medpace Holdings (MEDP – Research Report).

Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...

Research analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for shares of Maze Therapeutics in ...

Fintel reports that on March 28, 2025, Leerink Partners downgraded their outlook for Equillium (NasdaqCM:EQ) from Outperform to Market Perform. Analyst Price Forecast Suggests 736.07% Upside As of ...

Fintel reports that on March 28, 2025, Leerink Partners downgraded their outlook for Equillium (LSE:0A4D) from Outperform to Market Perform. There are 35 funds or institutions reporting positions ...

Some are about to move in with their partners. Others are deciding if they should have kids. Doing loyalty tests "can be a little triggering sometimes," Ari says, reminding her of when she was cheated ...

Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. According to TipRanks, Risinger is a 5-star analyst with an average return of 9 ...